Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

By Brian Buntz | August 11, 2022

Taro Pharmaceuticals announces Type I recall of Taro-zoledronic acid injection

Taro Pharmaceuticals

The Canadian division of Taro Pharmaceuticals (NYSE:TARO) has announced a voluntary Type 1 recall on six lots of Taro-zoledronic Acid Injection. Type 1 recalls, according to Health Canada, refer to products that could cause serious adverse health consequences or death. It corresponds to Class 1 recalls from the FDA. Taro Pharmaceutical‘s consumer-level recall covers 5 mg/100…

By Sean Whooley | August 10, 2022

Biogen is scaling back space outside Boston

Biogen logo

According to reports, Biogen has taken steps to scale back costs following the release of its Aduhelm Alzheimer’s disease drug. The company has moved to sublease more than 260,000 square feet at multiple locations in Massachusetts as it looks to cut $1 billion in costs, The Boston Globe reported. Across from its Cambridge, Massachusetts, headquarters, the…

By Brian Buntz | August 8, 2022

Fresenius Kabi plans to add 2D barcodes to its pharmaceutical portfolio

Fresenius Kabi

Fresenius Kabi has announced a three-year plan to add GS1 Data Matrix barcodes to its pharmaceutical portfolio.  GS1 Data Matrix barcodes are also known as 2D barcodes.  The company manufactures a range of vials, syringes, IV products and parenteral nutrition products.   The Lake Zurich, Illinois–based company says the decision will reduce the need for manual data entry…

By Brian Buntz | August 8, 2022

Democrats’ drug pricing plan attracts pushback from Republicans

Dollars for drugs

Democrats’ climate change/anti-inflation bill that the Senate passed over the weekend includes a drug pricing plan. In particular, the Inflation Reduction Act legislation would give Medicare the ability to negotiate drug prices. The legislation is now headed the House. A group of Republican physicians wrote a letter to Senate Majority Leader Charles Schumer (D-NY) and…

By Brian Buntz | August 8, 2022

Pfizer to scoop up Global Blood Therapeutics for $5.4 billion 

GBT/Pfizer

After a banner year in 2021, Pfizer (NYSE:PFE) is on a spending spree. The company plans to acquire Global Blood Therapeutics (GBT) (Nasdaq:GBT) for $68.50 per share. The total sale price of acquisition, if it moves forward, would be roughly $5.4 billion. Global Blood Therapeutics’s therapeutic focus is primarily on sickle cell disease. In March,…

By Brian Buntz | August 3, 2022

How fentanyl has transformed the opioid crisis

fentanyl

In the 1990s, growing use of painkillers such as Percocet and Oxycodone helped seed the opioid epidemic. Afterward, demand for heroin increased, exacerbating the problem. More recently, a surge in  synthetic opioid fentanyl use has worsened the crisis. According to the CDC, more than 100,000 Americans now die from drug overdoses yearly. Of those, approximately…

By Brian Buntz | August 1, 2022

AstraZeneca installs Michel Demaré as non-executive board chair 

AstraZeneca

AstraZeneca (LON:AZN) has appointed Michel Demaré as the chair-designate of its board. Demaré will replace Leif Johansson, the current chair of the board of AstraZeneca, who plans to retire in April 2023. There will be a managed handover period in the coming months. Demaré joined AstraZeneca’s board of directors in September 2019 as an independent…

By Brian Buntz | July 29, 2022

Astellas to spend $70M on new biotech campus in South San Francisco

Astellas

Astellas Pharma (TSE: 4503) plans to establish a biotech campus in South San Francisco, California, as the core of its West Coast R&D operations. Located near Genentech and Verily Life Sciences facilities, the site at 480 Forbes Boulevard will consolidate several Astellas business units and functions currently based throughout the San Francisco Bay Area. The…

By Sean Whooley | July 28, 2022

Senate Finance Committee chair says Abbott, Merck aren’t complying

U.S. Senate Finance Committee Chair Ron Wyden D-Oregon

Senate Finance Committee Chair Ron Wyden (D-Oregon) wrote a letter demanding compliance from Merck and Abbott. The letter demands that Merck and Abbott complay with the Senate Finance Committee’s investigation into the tax practices of Big Pharma. According to a news release from the Senate Finance Committee, the two companies have, to this point, “stonewalled”…

By Brian Buntz | July 26, 2022

Ultra Supplement announces recall for undeclared tadalafil

FDA logo

The FDA continues to pressure manufacturers and distributors for selling products with undeclared sildenafil and tadalafil. The agency recently announced that Wilmington Delaware–based Ultra Supplement LLC is voluntarily recalling lot number DAP272109 of Sustango capsules over the presence of tadalafil (Cialis). The company markets the product as a supplement for men. Sustango was available for…

Next >

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards